Indo Borax & Chemicals Board Approves FY26 Audited Results and Recommends Substantial Dividends
Indo Borax & Chemicals Limited reported audited standalone net profit of ₹4,973.97 lakh and consolidated net profit of ₹5,026.98 lakh for FY26. The Board recommended a final dividend of ₹10 and a special dividend of ₹30 per share for FY26, subject to shareholder approval at the AGM.
The recommendation of significant dividends and the approval of annual financial results are material events for shareholders, impacting the company's valuation and investor sentiment.
The company reported positive financial results and recommended substantial dividends, which is generally viewed favorably by investors.
The Board of Directors of Indo Borax & Chemicals Limited, in a meeting held on May 21, 2026, has approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Concurrently, the Board recommended a final dividend of ₹10 per equity share and a special dividend of ₹30 per equity share for the financial year 2025-26. These dividends are subject to shareholder approval at the upcoming 45th Annual General Meeting (AGM). The company also reported that the financial results are available on its website, www.indoborax.com. The Board also approved the appointment of M/s. Shah Kapadia & Associates as Internal Auditors and the re-appointment of M/s. V. B. Modi & Associates as Cost Auditors for FY 2026-27, subject to shareholder ratification for the latter's remuneration. Additionally, the Nomination and Remuneration Committee (NRC) of the company has been reconstituted.
The financial statements for the year ended March 31, 2026, show a revenue from operations of ₹21,545.11 lakh (standalone) and ₹21,545.11 lakh (consolidated). The net profit after tax for the period was ₹4,973.97 lakh (standalone) and ₹5,026.98 lakh (consolidated). The company's audited standalone financial results indicate a total comprehensive income of ₹5,376.25 lakh, with an Earnings Per Share (EPS) of ₹15.50 (basic & diluted). The consolidated results show a total comprehensive income of ₹5,435.89 lakh, with an EPS of ₹15.67 (basic & diluted).
During the year, the company had an Inter Corporate Deposit in the nature of a loan of ₹5.09 crore to a party that has filed for corporate insolvency resolution. The company has filed its claim as a financial creditor and is awaiting the outcome from the National Company Law Tribunal (NCLT), hence not providing interest on the said loan for the financial year ended March 31, 2026.
What to do with a filing like this
Indo Borax & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Borax & Chemicals Limited. Read the original for the full detail.